Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 149

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 149
---
 future patents. We may be unaware of patents that a third party, including, for example, a competitor in the genetic testing market, might assert are infringed by our business. There may also be patent applications that, if issued as patents, could be asserted against us. Third parties making claims against us for infringement or misappropriation of their intellectual property rights may seek and obtain injunctive or other equitable relief, which could effectively block our ability to perform our tests. Further, if a patent infringement or misappropriation of intellectual property lawsuit were brought against us, we could be forced to stop or delay our development or sales of any tests or other activities that are the subject of such suit. Defense of these 54 claims, regardless of merit, could cause us to incur substantial expenses and be a substantial diversion of our employee resources. Any adverse ruling or perception of an adverse ruling in defending ourselves could have a material adverse impact on our business and share price. In the event of a successful claim of infringement against us by a third party, we may have to (i) pay substantial damages, possibly including treble damages and attorneys’ fees if we are found to have willfully infringed patents; (ii) obtain one or more licenses, which may not be available on commercially reasonable terms (if at all); (iii) pay royalties; and/or (iv) redesign any infringing tests or other activities, which may be impossible or require substantial time and monetary expenditure, all of which could have a material adverse impact on our cash position and business, financial condition, results of operations or growth prospects. If licenses to third -partyintellectual property rights are or become required for us to engage in our business, we may be unable to obtain them at a reasonable cost, if at all. Even if such licenses are available, we could incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our gross margins. Moreover, we could encounter delays in the introduction of tests while we attempt to develop alternatives. Defense of any lawsuit or failure to obtain any of these licenses on favorable terms could prevent us from commercializing tests, which could materially affect our ability to grow and thus adversely affect our business and financial condition. We may be subject to claims challenging the inventorship or ownership of our intellectual property. We may be subject to claims that former employees, collaborators or other third parties have an interest in our owned or in -licensedpatents, trade secrets or other intellectual property as an inventor or co -inventor. Although